Evidence map›Paper›PMID 25613734›Full record

ArticleScientific reports2015

Evolutionary analysis of rubella viruses in mainland China during 2010-2012: endemic circulation of genotype 1E and introductions of genotype 2B.

Zhen Zhu, Pierre Rivailler, Emily Abernathy, Aili Cui, Yan Zhang, Naiyin Mao, Songtao Xu, Shujie Zhou, Yue Lei, Yan Wang and 24 more

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Epidemiological and molecular investigation of a rubella outbreak, Romania, 2011 to 2012.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2016
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Zhen ZhuWHO WPRO Regional Reference Measles/Rubella Laboratory and Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Beijing, People's Republic of China.
Pierre RivaillerCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Emily AbernathyCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Aili CuiWHO WPRO Regional Reference Measles/Rubella Laboratory and Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Beijing, People's Republic of China.
Yan ZhangWHO WPRO Regional Reference Measles/Rubella Laboratory and Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Beijing, People's Republic of China.
Naiyin MaoWHO WPRO Regional Reference Measles/Rubella Laboratory and Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Beijing, People's Republic of China.
Songtao XuWHO WPRO Regional Reference Measles/Rubella Laboratory and Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Beijing, People's Republic of China.
Shujie ZhouAnhui Provincial Centers for Disease Control and Prevention, People's Republic of China.
Yue LeiTianjin Provincial Centers for Disease Control and Prevention, People's Republic of China.
Yan WangLiaoning Provincial Centers for Disease Control and Prevention, People's Republic of China.
Huanying ZhengGuangdong Provincial Centers for Disease Control and Prevention, People's Republic of China.
Jilan HeSichuan Provincial Centers for Disease Control and Prevention, People's Republic of China.
Ying ChenGansu Provincial Centers for Disease Control and Prevention, People's Republic of China.
Chongshan LiShanghai Provincial Centers for Disease Control and Prevention, People's Republic of China.
Fang BoHeilongjiang Provincial Centers for Disease Control and Prevention, People's Republic of China.
Chunfang ZhaoChongqing Provincial Centers for Disease Control and Prevention, People's Republic of China.
Meng ChenBeijing Provincial Centers for Disease Control and Prevention, People's Republic of China.
Peishan LuJiangsu Provincial Centers for Disease Control and Prevention, People's Republic of China.
Fangcai LiHunan Provincial Centers for Disease Control and Prevention, People's Republic of China.
Suyi GuNeimeng Provincial Centers for Disease Control and Prevention, People's Republic of China.
Hui GaoShanxi Provincial Centers for Disease Control and Prevention, People's Republic of China.
Yu GuoHebei Provincial Centers for Disease Control and Prevention, People's Republic of China.
Hui ChenNingxia Provincial Centers for Disease Control and Prevention, People's Republic of China.
Daxing FengHenan Provincial Centers for Disease Control and Prevention, People's Republic of China.
Shuang WangJilin Provincial Centers for Disease Control and Prevention, People's Republic of China.
Xiaomin TangGuizhou Provincial Centers for Disease Control and Prevention, People's Republic of China.
Yake LeiHubei Provincial Centers for Disease Control and Prevention, People's Republic of China.
Yan FengZhejiang Provincial Centers for Disease Control and Prevention, People's Republic of China.
Lili DengGuangxi Provincial Centers for Disease Control and Prevention, People's Republic of China.
Tian GongJiangxi Provincial Centers for Disease Control and Prevention, People's Republic of China.
Lixia FanQinghai Provincial Centers for Disease Control and Prevention, People's Republic of China.
Wenbo XuWHO WPRO Regional Reference Measles/Rubella Laboratory and Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Beijing, People's Republic of China.
Joseph IcenogleCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Rubella Virology Surveillance Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rubella remains a significant burden in mainland China. In this report, 667 viruses collected in 24 of 31 provinces of mainland China during 2010-2012 were sequenced and analyzed, significantly extending previous reports on limited numbers of viruses collected before 2010. Only viruses of genotypes 1E and 2B were found. Genotype 1E viruses were found in all 24 provinces. Genotype 1E viruses were likely introduced into mainland China around 1997 and endemic transmission of primarily one lineage became established. Viruses reported here from 2010-2012 are largely in a single cluster within this lineage. Genotype 2B viruses were rarely detected in China prior to 2010. This report documents a previously undetected 2B lineage, which likely became endemic in eastern provinces of China between 2010 and 2012. Bayesian analyses were performed to estimate the evolutionary rates and dates of appearance of the genotype 1E and 2B viral linages in China. A skyline plot of viral population diversity did not provide evidence of reduction of diversity as a result of vaccination, but should be useful as a baseline for such reductions as vaccination programs for rubella become widespread in mainland China.

Indexed as

Evolution, MolecularGenotypeChinaGenetic VariationGeographyHumansIncidencePhylogenyRNA, ViralRubellaRubella virusSequence Analysis, DNAViral Envelope ProteinsE1 envelope protein, Rubella virusRNA, ViralViral Envelope Proteins

Identifiers

PMID25613734
PMCPMC4303870

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.